comparemela.com

Latest Breaking News On - Pharma industries - Page 1 : comparemela.com

Transcripts For CNBC Squawk Box 20171127

Percent. Shanghai stocks down by close to 1 a decline of more than nine tenths in europe there have been some green arrows the dax is up by. 2 the cac is up by a quarter percentage points. Stocks up in italy, spain and london crude oil prices which ended last week just shy of 59 a barrel, check this out right now, down by about 44 cents. Still, wti trading above 58 at 58. 51 a barrel. Now this morning the big news of the day. Publisher meredith buying time, inc. , for2. 8 billion thats the price meredith will pay 18. 50 for time, inc. It publishes wellknown magazines such as time, peopl people. Meredith received 650 million a lot of people raising questions about what this means. Raising 650 million in backing from the billionaire Koch Brothers, charles and david koch are widely known for supporting conservative causes. They say the magazine business is a good investment in the press release koch industry says it will not have any seat on merediths board and will have no influence or e

New-york
United-states
Japan
Shanghai
China
Washington
Whitehouse
District-of-columbia
Michigan
Germany
Jersey
Maine

Transcripts For CSPAN3 Food Drug Administration Oversight 20180116

[ is distinct conversations ]. And live here this morning on c spann span 3, a discussion about transparency and oversight at the food and Drug Administration. Well be hearing from dr. Scott gottlieb starting off the conference. Introductions under way. Efforts to pass and implement the food safety modernization act, focus on medical devices, especially the potential of using the unique device identifier to improve monitoring devices throughout the product lifecycle. We have successfully worked on products 10 to courage innovation particularly around antibiotics and 10 to sure appropriate use of them. We focused on drug safety and transparency in the supply chain and especially on the safety of compounded drugs. Among other things, pew submitted transparency to the task force back in 2010 if the. They touch on some of the topics well be discussing today. Reading the background papers for todays meet regular mind med of a meeting we convened in a room directly above of us here a few yea

Acton
Ontario
Canada
United-states
Kentucky
Guinea
Mecca
Makkah
Saudi-arabia
Togo
Oregon
Canadian

Transcripts For CSPAN3 FDA Transparency - Panel 2 - Investors 20180117

Investors. During this portion of the event we hear from jonathan left, chair of the deerfield institute. Its 25 minutes. Thank you so much for coming. Chairman of the deerfield institute, he joined this company in 2013. The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served on the emerging Company Section board on the Bio Technology board industry organization. Hes served on many nonprofit boards. He is a graduate of Harvard University and the Stanford School of business. And we really appreciate your coming. Thank you. And its great to be here. Were going to talk. Im going to start with a provocative question. Does the Investment Community view the u. S. , food and

Rhode-island
United-states
Virginia
North-carolina
Washington
Raleigh
Jason-lewis
Bob-dole
Josh-stein
Venture-capital
Bio-technology
Committee-board

Transcripts For CSPAN3 FDA Transparency - Panel 2 - Investors 20180117

The company focuses on Venture Capital and structured investments and Bio Technology and pharmaceuticals. Prior for 16 years he led the firms in investment in Bio Technology and pharmaceuticals. Hes been active in policy discussions, served on the executive committee on the board of national Venture Capital association and led that groups Life Sciences efforts. Hes also served on the emerging Company Section board on the Bio Technology board industry organization. Hes served on many nonprofit boards. He is a graduate of Harvard University and the Stanford School of business. And we really appreciate your coming. Thank you. And its great to be here. Were going to talk. Im going to start with a provocative question. Does the Investment Community view the u. S. , food and Drug Administration as a Necessary Evil or as a critical ally or or Something Else . Thats a great question. I obviously cant speak on the behalf of the entire Investment Community, but i would say overwhelmingly fda is

Rhode-island
United-states
Virginia
North-carolina
Washington
Raleigh
Jason-lewis
Bob-dole
Josh-stein
Venture-capital
Bio-technology
Committee-board

Transcripts For CSPAN2 Hoover Institution Forum Considers The Future Of FISA 20170601

The research focuses on the intersection of technology, policy, business losses wider ramifications of key technological trends and development. He testified before congress more recently on drums, privacy and intellectual property and also the broad for the Global Agenda Council and cybersecurity. John is going to go through the basics of sections of a note to and sort of like a onetoone introduction and for the rest of our program today. John, welcome good thank you for coming today. I realize theres probably some countrys top experts on seven of two of the room and perhaps people who know a little more. If youre one of the countrys top, you will learn nothing in the next 25, 30 minutes. The goal of this portion of the talk is to make sure we are all starting to think foundation. Im not going to argue in favor or against section 702. I am going to lay out the same place. My understanding is programmatically this one goes until 12 45 in the without much for you and will come back and

New-york
United-states
Washington
Whitehouse
District-of-columbia
Syria
Russia
Pakistan
Ukraine
Benin
Idaho
Israel

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.